Peces R, Rodríguez M, Pobes A, Seco M
Services of Nephrology and Pathology, Hospital Central de Asturias, Oviedo, Spain.
Am J Kidney Dis. 2000 May;35(5):954-7. doi: 10.1016/s0272-6386(00)70269-1.
We report a case of rapidly progressive glomerulonephritis caused by anti-glomerular basement membrane (anti-GBM) antibodies that progressed to end-stage renal disease in a 67-year-old woman with diabetes. Intensive combined immunosuppressive therapy with methylprednisolone bolus, oral prednisone, and cyclophosphamide led to negativity of anti-GBM antibodies but was not able to restore renal function. After 28 months of hemodialysis, the patient suddenly presented with pulmonary hemorrhage. In this setting, high levels of myeloperoxidase (MPO)-antineutrophil cytoplasmic antibody (ANCA) and negative anti-GBM antibodies were found. Therapy with oral prednisone and cyclophosphamide led to resolution of pulmonary hemorrhage and negativity of MPO-ANCA.
我们报告一例由抗肾小球基底膜(anti-GBM)抗体引起的快速进展性肾小球肾炎病例,该病例发生在一名患有糖尿病的67岁女性身上,最终进展为终末期肾病。采用甲泼尼龙冲击、口服泼尼松和环磷酰胺进行强化联合免疫抑制治疗后,抗GBM抗体转阴,但未能恢复肾功能。在进行28个月的血液透析后,患者突然出现肺出血。在此情况下,发现髓过氧化物酶(MPO)-抗中性粒细胞胞浆抗体(ANCA)水平升高,而抗GBM抗体为阴性。口服泼尼松和环磷酰胺治疗使肺出血得到缓解,MPO-ANCA转阴。